These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9125617)

  • 41. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
    Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Activated protein C resistance and deep venous thrombosis in pregnancy].
    Procházka M; Krcová V; Hrachovec P; Kudela M; Slavík L
    Ceska Gynekol; 2002 Sep; 67(5):251-4. PubMed ID: 12434659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor V Leiden and fatal pulmonary embolism.
    Vandenbroucke JP; Bertina RM; Holmes ZR; Spaargaren C; van Krieken JH; Manten B; Reitsma PH
    Thromb Haemost; 1998 Mar; 79(3):511-6. PubMed ID: 9531031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF; Lensen RP; Bertina RM
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation.
    McColl M; Tait RC; Walker ID; Perry DJ; McCall F; Conkie JA
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):689-94. PubMed ID: 8958391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism.
    Martinelli I; Cattaneo M; Panzeri D; Mannucci PM
    Thromb Haemost; 1997 Mar; 77(3):440-3. PubMed ID: 9065990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis.
    Mandel H; Brenner B; Berant M; Rosenberg N; Lanir N; Jakobs C; Fowler B; Seligsohn U
    N Engl J Med; 1996 Mar; 334(12):763-8. PubMed ID: 8592550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.
    Haim N; Lanir N; Hoffman R; Haim A; Tsalik M; Brenner B
    Am J Med; 2001 Feb; 110(2):91-6. PubMed ID: 11165549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to activated protein C and factor V Leiden.
    Perry DJ; Pasi KJ
    QJM; 1997 Jun; 90(6):379-85. PubMed ID: 9205675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis.
    Meyer G; Emmerich J; Helley D; Arnaud E; Nicaud V; Alhenc-Gelas M; Aiach M; Fischer A; Sors H; Fiessinger JN
    Am J Med; 2001 Jan; 110(1):12-5. PubMed ID: 11152859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factor V Leiden: association with venous thromboembolism in pregnancy and screening issues.
    Harvey D; Lowe GM
    Br J Biomed Sci; 2004; 61(3):157-64. PubMed ID: 15462267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I
    Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome.
    Krauss T; Augustin HG; Osmers R; Meden H; Unterhalt M; Kuhn W
    Obstet Gynecol; 1998 Sep; 92(3):457-60. PubMed ID: 9721789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.
    Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL
    Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?
    Biswas A; Bajaj J; Ranjan R; Meena A; Akhter MS; Yadav BK; Sharma V; Saxena R
    Clin Chim Acta; 2008 Jun; 392(1-2):21-4. PubMed ID: 18342013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance).
    Rosendaal FR; Koster T; Vandenbroucke JP; Reitsma PH
    Blood; 1995 Mar; 85(6):1504-8. PubMed ID: 7888671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm.
    Van Cott EM; Soderberg BL; Laposata M
    Arch Pathol Lab Med; 2002 May; 126(5):577-82. PubMed ID: 11958664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.